Pricing Log in Create free account

Charles River Laboratories International, Inc. (CRL) vs Revvity Inc. (RVTY)

Charles River Laboratories International, Inc. and Revvity Inc. are both Diagnostics & Research companies. Revvity Inc. is the larger, with a market value of $16.8B against $14.9B — 1.1× the size. Revvity Inc. trades at the lower P/E: 71.9× against 300×. Revvity Inc. grew revenue faster over the last twelve months: 4.56% against −1.16%. Revvity Inc. has the higher net margin (8.61% vs 1.01%) and the higher return on invested capital (2.50% vs 1.81%). Across the 22 metrics below, Revvity Inc. leads on 17 and Charles River Laboratories International, Inc. on 5.

Valuation

Metric CRL RVTY Diagnostics & Research median
P/E 300.09 71.89 34.52
P/S 3.77 5.73 4.24
P/B 4.64 2.33 3.42
Price to free cash flow 37.56 28.19 33.51
EV/EBITDA 31.20 25.08 23.44
EV/Sales 4.34 6.61 5.18
Earnings yield 0.33% 1.39% (1.50%)
Free cash flow yield 2.66% 3.55% 0.00%

Profitability

Metric CRL RVTY Diagnostics & Research median
Gross margin 33.33% 55.91% 48.32%
Operating margin 4.00% 12.65% (5.68%)
Net margin 1.01% 8.61% (4.10%)
Free cash flow margin 10.05% 20.48% 0.00%
Return on equity 1.21% 0.00% 0.00%
Return on assets 0.54% 2.14% (6.05%)
Return on invested capital 1.81% 2.50% 0.00%

Growth

Metric CRL RVTY Diagnostics & Research median
Revenue growth (TTM) (1.16%) 4.56% 8.99%
EPS growth (last fiscal year) (1,555.00%) (5.91%) 20.36%
Revenue growth, 5-year CAGR 6.55% 1.41% 7.30%
Net income growth, 5-year CAGR 0.00% (19.82%) 0.00%

Health

Metric CRL RVTY Diagnostics & Research median
Debt to equity 0.76 0.36 0.01
Current ratio 1.41 2.65 2.27
Net debt to EBITDA 3.24 3.00 0.68

Dividend

Metric CRL RVTY Diagnostics & Research median
Dividend yield — 0.19% 0.67%
Payout ratio — 0.12 0.20

Size

Metric CRL RVTY Diagnostics & Research median
Market cap 14.94b 16.83b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack